Plain-English translation of NCT07627074 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of , a medication that helps people lose weight. Researchers are following thousands of adults who are already using this medication as part of their routine care to understand how well it works for weight loss in everyday medical practice.
While this medication has been tested in controlled research settings, researchers want to know how it actually performs when prescribed and used by patients in normal clinical practice, where people may have different health histories and lifestyles.
You likely qualify if…
You likely don't qualify if…
You don't need to do anything special for this study — it uses information already collected during your regular doctor visits. Researchers will follow your health records for about 68 weeks (roughly 15 months) while you take the medication as prescribed by your doctor. No extra study visits, tests, or procedures are required.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States
United Kingdom
Enrollment target
~35,000 participants
Started
May 2026
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Novo Nordisk
Novo Nordisk A/S
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.